Jason Aryeh
Role in collected records: Director. Collected issuer coverage: LGND. Form 4 rows and their summary range show transaction dates from collected records. The separate Form 144 table shows filing dates. Open the linked filings for their full terms and submission details. Filed as Aryeh Jason.
Collected Form 4 transaction rows
Reported purchases, sales, grants, exercises and other changes. One filing can contain multiple transaction rows.
| Company | Action | Value |
|---|---|---|
| LGNDLigand Pharmaceuticals Inc2026-11-04 | Sale | $90.2K |
| LGNDLigand Pharmaceuticals Inc2026-11-02 | Sale | $224.3K |
| LGNDLigand Pharmaceuticals Inc2026-10-30 | Sale | $15.9K |
| LGNDLigand Pharmaceuticals Inc2026-10-30 | Sale | $15.9K |
| LGNDLigand Pharmaceuticals Inc2026-10-30 | Sale | $16.7K |
| LGNDLigand Pharmaceuticals Inc2026-10-30 | Sale | $387.4K |
| LGNDLigand Pharmaceuticals Inc2026-10-30 | Sale | $16K |
Sales they filed notice of
Form 144 gives notice of a proposed sale under Rule 144. It is not SEC approval or proof of a completed sale; these notices are kept separate from the transaction rows above.
Source: collected SEC Form 4 records and Form 144 notices via EDGAR. This site matches Form 144 seller names exactly to the collected Form 4 filed name; a name match alone does not establish identity. Form 4 transaction value uses reported shares and price and is blank for zero or missing prices. That does not establish an award’s economic value. Records may be incomplete; a sale alone does not establish motive. SEC guide to insider reports.
Follow Jason Aryeh by email
Jason Aryeh's new Form 4 trades, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.